AMAG Pharmaceuticalsの収益YQ/Q
AMAG Pharmaceuticalsの収益YQ/Qは何ですか。
AMAG Pharmaceuticals, Inc.の収益YQ/Qは10.67%です。
収益YQ/Qの定義は何ですか。
四半期収益成長率、前年比は、前年同期の業績と比較して、売上高の増加率がパーセンテージとして表されています。
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
NASDAQのセクタHealth Careにおける収益YQ/Qの企業と比べるAMAG Pharmaceuticals
AMAG Pharmaceuticalsは何をしますか。
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
AMAG Pharmaceuticalsと類似の収益yq/q
- NextGen Healthcare Incの収益YQ/Qは10.65%です。
- CTI Logisticsの収益YQ/Qは10.65%です。
- Delta Drone SAの収益YQ/Qは10.66%です。
- Forum Technologies Incの収益YQ/Qは10.66%です。
- Mindteck (India)の収益YQ/Qは10.66%です。
- HT Mediaの収益YQ/Qは10.66%です。
- AMAG Pharmaceuticalsの収益YQ/Qは10.67%です。
- Kenmare Resources plcの収益YQ/Qは10.68%です。
- Tokyo Plast Internationalの収益YQ/Qは10.68%です。
- Adani Transmissionsの収益YQ/Qは10.68%です。
- HNIの収益YQ/Qは10.68%です。
- Yongguan Adhesiveの収益YQ/Qは10.69%です。
- INDUS AGの収益YQ/Qは10.69%です。